1-2 of 2
Wei Sang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study

Clinical Trials & Observations
Emmanuel Bachy, Kerry J. Savage, Huiqiang Huang, Yok-Lam Kwong, Giuseppe Gritti, Qingyuan Zhang, Anna Marina Liberati, Junning Cao, Haiyan Yang, Siguo Hao, Jianda Hu, Keshu Zhou, Mario Petrini, Filomena Russo, Huilai Zhang, Wei Sang, Jie Ji, Andrés José María Ferreri, Gandhi Laurent Damaj, Hui Liu, Wei Zhang, Xiaoyan Ke, Chiara Ghiggi, Sha Huang, Xiaotong Li, Hui Yao, Jason Paik, William Novotny, Wenxiao Zhou, Hongjie Zhu, Pier Luigi Zinzani
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4435–4447.
https://doi.org/10.1182/bloodadvances.2022009575
Published: 2023
Includes: Supplemental data
Journal Articles

Humoral immune reconstitution after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma

Clinical Trials & Observations
Ying Wang, Chunrui Li, Jieyun Xia, Ping Li, Jiang Cao, Bin Pan, Xu Tan, Hujun Li, Kunming Qi, Xiangmin Wang, Ming Shi, Guangjun Jing, Zhiling Yan, Hai Cheng, Feng Zhu, Haiying Sun, Wei Sang, Depeng Li, Xi Zhang, Zhenyu Li, Junnian Zheng, Aibin Liang, Jianfeng Zhou, Kailin Xu
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5290–5299.
https://doi.org/10.1182/bloodadvances.2021004603
Published: 2021
Includes: Supplemental data